These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26389963)

  • 1. cAMP-Inhibits Cytoplasmic Phospholipase A₂ and Protects Neurons against Amyloid-β-Induced Synapse Damage.
    Bate C; Williams A
    Biology (Basel); 2015 Sep; 4(3):591-606. PubMed ID: 26389963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanol protects cultured neurons against amyloid-β and α-synuclein-induced synapse damage.
    Bate C; Williams A
    Neuropharmacology; 2011 Dec; 61(8):1406-12. PubMed ID: 21903110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein-induced synapse damage in cultured neurons is mediated by cholesterol-sensitive activation of cytoplasmic phospholipase A2.
    Bate C; Williams A
    Biomolecules; 2015 Mar; 5(1):178-93. PubMed ID: 25761116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glimepiride protects neurons against amyloid-β-induced synapse damage.
    Osborne C; West E; Nolan W; McHale-Owen H; Williams A; Bate C
    Neuropharmacology; 2016 Feb; 101():225-36. PubMed ID: 26432105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.
    Bate C; Williams A
    Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins.
    Bate C; Williams A
    J Biol Chem; 2011 Nov; 286(44):37955-37963. PubMed ID: 21900234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-synuclein induced synapse damage is enhanced by amyloid-β1-42.
    Bate C; Gentleman S; Williams A
    Mol Neurodegener; 2010 Dec; 5():55. PubMed ID: 21138585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage.
    West E; Osborne C; Nolan W; Bate C
    Biology (Basel); 2015 Jun; 4(2):367-82. PubMed ID: 26043272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squalestatin protects neurons and reduces the activation of cytoplasmic phospholipase A2 by Abeta(1-42).
    Bate C; Williams A
    Neuropharmacology; 2007 Aug; 53(2):222-31. PubMed ID: 17583757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β(1-40) inhibits amyloid-β(1-42) induced activation of cytoplasmic phospholipase A2 and synapse degeneration.
    Bate C; Williams A
    J Alzheimers Dis; 2010; 21(3):985-93. PubMed ID: 20634578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoquinone protects cultured hippocampal and human induced pluripotent stem cells-derived neurons against α-synuclein-induced synapse damage.
    Alhebshi AH; Odawara A; Gotoh M; Suzuki I
    Neurosci Lett; 2014 Jun; 570():126-31. PubMed ID: 24080376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipase A2 inhibitors protect against prion and Abeta mediated synapse degeneration.
    Bate C; Tayebi M; Williams A
    Mol Neurodegener; 2010 Apr; 5():13. PubMed ID: 20374666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cholesterol ester cycle regulates signalling complexes and synapse damage caused by amyloid-β.
    West E; Osborne C; Bate C
    J Cell Sci; 2017 Sep; 130(18):3050-3059. PubMed ID: 28760925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro model for synaptic loss in neurodegenerative diseases suggests a neuroprotective role for valproic acid via inhibition of cPLA2 dependent signalling.
    Williams RS; Bate C
    Neuropharmacology; 2016 Feb; 101():566-75. PubMed ID: 26116815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol ester hydrolase inhibitors reduce the production of synaptotoxic amyloid-β oligomers.
    McHale-Owen H; Bate C
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):649-659. PubMed ID: 29247837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
    Culvenor JG; McLean CA; Cutt S; Campbell BC; Maher F; Jäkälä P; Hartmann T; Beyreuther K; Masters CL; Li QX
    Am J Pathol; 1999 Oct; 155(4):1173-81. PubMed ID: 10514400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breaking the Cycle, Cholesterol Cycling, and Synapse Damage in Response to Amyloid-β.
    Bate C
    J Exp Neurosci; 2017; 11():1179069517733096. PubMed ID: 29238218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialylated glycosylphosphatidylinositols suppress the production of toxic amyloid-β oligomers.
    Nolan W; McHale-Owen H; Bate C
    Biochem J; 2017 Aug; 474(17):3045-3058. PubMed ID: 28729427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses.
    Willén K; Sroka A; Takahashi RH; Gouras GK
    J Alzheimers Dis; 2017; 60(2):511-524. PubMed ID: 28869466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taxifolin prevents β-amyloid-induced impairments of synaptic formation and deficits of memory via the inhibition of cytosolic phospholipase A
    Wang Y; Wang Q; Bao X; Ding Y; Shentu J; Cui W; Chen X; Wei X; Xu S
    Metab Brain Dis; 2018 Aug; 33(4):1069-1079. PubMed ID: 29542038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.